Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Doxazosin mesylate and saw palmetto cause genetic changes in fruit flies.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

The treatment combination is effective and generally safe for lung cancer.

Exosomes from Pinctada martensii mucus can safely reduce melanin production, offering a new treatment for skin pigment issues.

Baricitinib improved hair loss and arthritis in a lupus patient.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

A new therapy for a skin blistering condition has not been developed yet.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Finasteride helps female-pattern hair loss.

Centipeda minima and brevilin A protect skin cells from damage and aging.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

A man had a severe allergic reaction to sulfasalazine, with symptoms improving after treatment and follow-up.